We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $17.3B
1-Year Est. Return 211.34%
This Fund
S&P 500
This Quarter Est. Return
+52.81%
1 Year Est. Return
+211.34%
3 Year Est. Return
+939.3%
5 Year Est. Return
+2,115.56%
10 Year Est. Return
+44,753.23%
AUM
$17.3B
AUM Growth
+$3.65B
Cap. Flow
-$454M
Cap. Flow %
-2.63%
Top 10 Hldgs %
16.32%
Holding
439
New
84
Increased
139
Reduced
108
Closed
85

Top Sells

Rank Stock Value
1
FN icon
Fabrinet
FN
+$240M
2
LITE icon
Lumentum
LITE
+$130M
3
BE icon
Bloom Energy
BE
+$118M
4
TSM icon
TSMC
TSM
+$114M
5
COHR icon
Coherent
COHR
+$90.8M

Sector Composition

Rank Sector Weight
1 Healthcare 27.73%
2 Technology 23.9%
3 Industrials 19.67%
4 Financials 9.01%
5 Consumer Discretionary 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
1
TSMC
TSM
$2.34T
$470M 2.72%
984,500
-280,390
-22% -$114M
DFTX
2
Definium Therapeutics
DFTX
$4.86B
$322M 1.87%
6,845,276
+933,387
+16% +$23.1M
PRAX icon
3
Praxis Precision Medicines
PRAX
$7.84B
$321M 1.86%
959,048
+9,823
+1% +$3.11M
XENE icon
4
Xenon Pharmaceuticals
XENE
$3.58B
$267M 1.55%
4,418,557
-73,096
-2% -$4.06M
SIMO icon
5
Silicon Motion
SIMO
$9.37B
$262M 1.52%
786,074
+276,099
+54% +$64M
SYRE icon
6
Spyre Therapeutics
SYRE
$7.56B
$249M 1.44%
2,799,166
+8,381
+0.3% +$612K
CRNX
7
DELISTED
Crinetics Pharmaceuticals
CRNX
$242M 1.4%
6,463,551
+67,629
+1% +$2.51M
APGE
8
DELISTED
Apogee Therapeutics
APGE
$231M 1.34%
1,740,101
-180,699
-9% -$16.3M
GH icon
9
Guardant Health
GH
$23.8B
$230M 1.33%
1,533,985
+9,703
+0.6% +$1.06M
PL icon
10
Planet Labs
PL
$6.34B
$223M 1.29%
6,721,154
-1,197,539
-15% -$44.3M
BAP icon
11
Credicorp
BAP
$30.7B
$217M 1.26%
557,228
+106,498
+24% +$36.4M
EWTX icon
12
Edgewise Therapeutics
EWTX
$4.27B
$192M 1.11%
4,728,623
+250,681
+6% +$8.64M
VICR icon
13
Vicor
VICR
$13B
$189M 1.09%
496,507
+307,044
+162% +$83.8M
UCTT
14
Ultra Clean Holdings
UCTT
$3.52B
$187M 1.08%
1,309,202
+246,826
+23% +$21.7M
CW icon
15
Curtiss-Wright
CW
$19.9B
$174M 1.01%
229,123
+3,364
+1% +$2.47M
XMTR icon
16
Xometry
XMTR
$5.77B
$171M 0.99%
1,768,213
+255,358
+17% +$18.2M
WULF icon
17
TeraWulf
WULF
$7.85B
$152M 0.88%
6,163,879
+100,879
+2% +$2.32M
SEPN
18
Septerna Inc
SEPN
$1.76B
$148M 0.86%
4,433,058
+37,486
+0.9% +$1.06M
NXT icon
19
Nextpower Inc. Common Stock
NXT
$12.3B
$144M 0.83%
1,207,194
+169,643
+16% +$20.9M
CECO icon
20
Ceco Environmental
CECO
$4.3B
$142M 0.82%
1,560,486
+920,594
+144% +$72.8M
CRDO icon
21
Credo Technology Group
CRDO
$39.7B
$141M 0.81%
+517,062
New +$102M
CRS icon
22
Carpenter Technology
CRS
$19.7B
$140M 0.81%
227,203
-88,254
-28% -$41.6M
IBN icon
23
ICICI Bank
IBN
$100B
$140M 0.81%
4,826,120
+569,260
+13% +$15.4M
LASR icon
24
nLIGHT
LASR
$2.33B
$138M 0.8%
1,986,119
+213,422
+12% +$14.9M
ONTO icon
25
Onto Innovation
ONTO
$14.1B
$134M 0.78%
354,650
+34,116
+11% +$9.65M

Similar funds

Driehaus Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Driehaus Capital Management held 439 positions worth $17.3B, up 27% from $13.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Driehaus Capital Management's Q2 2026 filing shows 84 new, 139 increased, 108 reduced and 85 closed positions. Its largest new stake was Cadence Design Systems: 293,693 shares worth $110M. The largest sale was Fabrinet, an estimated $240M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

  • Driehaus Capital Management's largest Q2 2026 buy was Cadence Design Systems: 293,693 shares worth $110M.
  • Driehaus Capital Management added most to Vicor in Q2 2026, an estimated $83.8M increase.
  • Driehaus Capital Management's biggest Q2 2026 reduction was Fabrinet, cutting an estimated $240M.
  • Driehaus Capital Management fully exited National Vision in Q2 2026, selling an estimated $89.9M.
  • Driehaus Capital Management's ten largest holdings make up 16% of its $17.3B portfolio in Q2 2026.
  • Driehaus Capital Management opened 84 new positions and closed 85 in Q2 2026.
  • Driehaus Capital Management's portfolio value rose 27% quarter-over-quarter to $17.3B.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.